The global injection pen market is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support.
Access Sample Papers of Injection Pen Market spread across 136 Pages, Profiling 12 Companies and Supported with 82 Tables and 40 Figures is now available at www.rnrmarketresearch.com/contacts…ple?rname=1381276 .
The report analyzes the injection pen market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Key Target Audience:
- Injection pen manufacturing companies
- Original equipment manufacturing companies
- Suppliers and distributors of injection pen
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Medical research institutes
- Business research and consulting service providers
- Venture capitalists
- Market research and consulting firms
North America is expected to witness the highest growth during 2017 to 2022.
The highest growth rate of the North American market is attributed to the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increasing number of awareness programs in that region.
More Information on Injection Pen Market with Top Trends and Company Profile at www.rnrmarketresearch.com/contacts/1381276 .
Global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies. The diabetes segment is expected to grow at the highest CAGR during the forecast period.
The high growth of the segment can be primarily attributed to the large diabetic population and favorable reimbursements for diabetic treatments in developed countries. The diabetes segment is further segmented into Insulin and GLP-1.
2 Market Ranking of OEM Companies
3 Market Share Analysis
4 Competitive Scenario
5 Product Launches
6 Regulatory Approvals
8 Agreements, Collaborations, and Partnerships
The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).
Global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular diseases, rheumatoid arthritis, and migraine). The diabetes segment is expected to grow at the highest CAGR during the forecast period.
The high growth of this segment can be attributed to the large diabetic population across the globe and the favorable reimbursement scenario for diabetes treatments in developed countries.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.